Biosimilars have the potential to change the way we think about, identify, and manage health problems. They are already impacting both clinical research and patient care, and this impact will only grow as our understanding and technologies improve. Written by a team of experienced specialists in clinical development, this book discusses various potential drug development strategies, the design and analysis of pharmacokinetics (PK) studies, and the design and analysis of efficacy studies.
Koop dit e-boek en ontvang er nog 1 GRATIS!
Taal Engels ● Formaat PDF ● Pagina’s 268 ● ISBN 9781482231700 ● Editor Kerry B. Barker & PhD Bo Jin ● Uitgeverij CRC Press ● Gepubliceerd 2016 ● Downloadbare 3 keer ● Valuta EUR ● ID 5022100 ● Kopieerbeveiliging Adobe DRM
Vereist een DRM-compatibele e-boeklezer